2C-C

2C-C
Clinical data
Other names	2,5-Dimethoxy-4-chlorophenethylamine; 4-Chloro-2,5-dimethoxyphenethylamine
Routes of; administration	Oral
Drug class	Serotonin 5-HT2 receptor agonist; Serotonergic psychedelic; Hallucinogen
ATC code	None;
Legal status
Legal status	BR: Class F2 (Prohibited psychotropics); CA: Schedule III; DE: Anlage I (Authorized scientific use only); US: Schedule I;
Pharmacokinetic data
Onset of action	1.5–2 hours
Duration of action	4–8 hours
Identifiers
	IUPAC name 2-(4-chloro-2,5-dimethoxyphenyl)ethan-1-amine;
CAS Number	88441-14-9 ;
PubChem CID	29979100;
ChemSpider	21106221 ;
UNII	0RO7MZY2LS;
ChEMBL	ChEMBL124733 ;
CompTox Dashboard (EPA)	DTXSID80893699 ;
ECHA InfoCard	100.218.153
Chemical and physical data
Formula	C10H14ClNO2
Molar mass	215.68 g·mol−1
3D model (JSmol)	Interactive image;
Melting point	220 to 221 °C (428 to 430 °F) (hydrochloride)
	SMILES COc1cc(CCN)c(cc1Cl)OC;
	InChI InChI=1S/C10H14ClNO2/c1-13-9-6-8(11)10(14-2)5-7(9)3-4-12/h5-6H,3-4,12H2,1-2H3 ; Key:CGKQFIWIPSIVAS-UHFFFAOYSA-N ;
	(verify)

2C-C, also known as 4-chloro-2,5-dimethoxyphenethylamine, is a psychedelic drug of the phenethylamine and 2C families. It is taken orally.

2C-C was first described in the scientific literature by Alice Cheng and Neal Castagnoli in 1984. It was described in greater detail by Alexander Shulgin in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved). The drug is Schedule I of section 202(c) of the Controlled Substances Act in the United States, signed into law as of July 2012 under the Food and Drug Administration Safety and Innovation Act.